Skip to main content
Top
Published in: Indian Journal of Gastroenterology 3/2017

01-05-2017 | Original Article

Translation and validation of chronic liver disease questionnaire (CLDQ) in Tamil language

Authors: Amit Goel, Karunanithi Arivazhagan, Avani Sasi, Vanathy Shanmugam, Seleena Koshi, Biju Pottakkat, C. P. Lakshmi, Ashish Awasthi

Published in: Indian Journal of Gastroenterology | Issue 3/2017

Login to get access

Abstract

Background

Chronic liver disease questionnaire (CLDQ), a self-administered quality-of-life (QOL) instrument for chronic liver disease (CLD) patients, was originally developed in English language. We aimed to translate and validate CLDQ in Tamil language (CLDQ-T).

Methods

CLDQ-T, prepared by two forward and two backward independent translations by four bilingual (Tamil and English) persons, and repeated iterative modifications, was validated in adult, native-Tamil patients with CLD. CLDQ-T was re-tested in some patients 2 weeks later. Convergent validity was assessed using Spearman’s correlation, and discriminant validity by comparison with World Health Organization’s brief QOL tool (WHOQOL-BREF). Reliability was assessed through internal consistency (Cronbach’s alpha) and test-retest reliability (intra-class correlation). Cutoff used for statistical significance was p<0.05.

Results

The study included 126 patients (age: mean [SD] 46 years [12.5]; male 104; cause: alcohol 42%, HBV 25%, HCV 4%, cryptogenic 29%; CTP class A 47%, B 37%, and C 16%). In convergent validity, all domains except the “abdominal domain” showed significant correlation between CLDQ-T and WHOQOL-BREF. Patients with severe disease had lower scores for all domains of CLDQ-T except the “abdominal” domain, but not for any of the domains for WHOQOL-BREF. Overall Cronbach’s alpha was 0.942, and more than 0.7 for all the individual domains except the “activity” domain. On retesting in 44 (35%) patients, intraclass correlation coefficient was 0.879 for the overall CLDQ-T score and >0.700 for individual domains.

Conclusion

CLDQ-T was easily understood and showed good performance characteristics in assessing QOL in Tamil-speaking patients with CLD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001;96:2199–205.CrossRefPubMed Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001;96:2199–205.CrossRefPubMed
2.
go back to reference Parkash O, Iqbal R, Jafri F, Azam I, Jafri W. Frequency of poor quality of life and predictors of health related quality of life in cirrhosis at a tertiary care hospital Pakistan. BMC Res Notes. 2012;5:446.CrossRefPubMedPubMedCentral Parkash O, Iqbal R, Jafri F, Azam I, Jafri W. Frequency of poor quality of life and predictors of health related quality of life in cirrhosis at a tertiary care hospital Pakistan. BMC Res Notes. 2012;5:446.CrossRefPubMedPubMedCentral
3.
go back to reference Gutteling JJ, de Man RA, Busschbach JJ, Darlington AS. Overview of research on health-related quality of life in patients with chronic liver disease. Neth J Med. 2007;65:227–34.PubMed Gutteling JJ, de Man RA, Busschbach JJ, Darlington AS. Overview of research on health-related quality of life in patients with chronic liver disease. Neth J Med. 2007;65:227–34.PubMed
4.
go back to reference Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45:295–300.CrossRefPubMedPubMedCentral Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45:295–300.CrossRefPubMedPubMedCentral
5.
go back to reference Hauser W, Schnur M, Steder-Neukamm U, Muthny FA, Grandt D. Validation of the German version of the Chronic Liver Disease Questionnaire. Eur J Gastroenterol Hepatol. 2004;16:599–606.CrossRefPubMed Hauser W, Schnur M, Steder-Neukamm U, Muthny FA, Grandt D. Validation of the German version of the Chronic Liver Disease Questionnaire. Eur J Gastroenterol Hepatol. 2004;16:599–606.CrossRefPubMed
6.
go back to reference Rucci P, Taliani G, Cirrincione L, et al. Validity and reliability of the Italian version of the chronic liver disease questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis. 2005;37:850–60.CrossRefPubMed Rucci P, Taliani G, Cirrincione L, et al. Validity and reliability of the Italian version of the chronic liver disease questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis. 2005;37:850–60.CrossRefPubMed
7.
go back to reference Ferrer M, Cordoba J, Garin O, et al. Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl. 2006;12:95–104.CrossRefPubMed Ferrer M, Cordoba J, Garin O, et al. Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl. 2006;12:95–104.CrossRefPubMed
8.
go back to reference Kim S, Choi KH, Hwang SG, et al. Validation of the Korean version of liver disease quality of life (LDQOL 1.0) instrument. Korean J Hepatol. 2007;13:44–50.PubMed Kim S, Choi KH, Hwang SG, et al. Validation of the Korean version of liver disease quality of life (LDQOL 1.0) instrument. Korean J Hepatol. 2007;13:44–50.PubMed
9.
go back to reference Benito de Vale M, Josefsson A, Lindkvist B, Kalaitzakis E. Validation of the Swedish version of the chronic liver disease questionnaire. Scand J Gastroenterol. 2012;47:614–5.CrossRefPubMed Benito de Vale M, Josefsson A, Lindkvist B, Kalaitzakis E. Validation of the Swedish version of the chronic liver disease questionnaire. Scand J Gastroenterol. 2012;47:614–5.CrossRefPubMed
10.
go back to reference Mahmoudi H, Jafari P, Alizadeh-Naini M, Gholami S, Malek-Hosseini SA, Ghaffaripour S. Validity and reliability of Persian version of Chronic Liver Disease Questionnaire (CLDQ). Qual Life Res. 2012;21:1479–85.CrossRefPubMed Mahmoudi H, Jafari P, Alizadeh-Naini M, Gholami S, Malek-Hosseini SA, Ghaffaripour S. Validity and reliability of Persian version of Chronic Liver Disease Questionnaire (CLDQ). Qual Life Res. 2012;21:1479–85.CrossRefPubMed
11.
go back to reference Mucci S, de Albuquerque CV, Gonzalez AM, et al. Validation of the Brazilian version of Chronic Liver Disease Questionnaire. Qual Life Res. 2013;22:167–72.CrossRefPubMed Mucci S, de Albuquerque CV, Gonzalez AM, et al. Validation of the Brazilian version of Chronic Liver Disease Questionnaire. Qual Life Res. 2013;22:167–72.CrossRefPubMed
12.
go back to reference Ranawaka CK, Miththinda JK, Senanayake SM, et al. Validation of the Sinhala version of the Chronic Liver Disease Questionnaire (CLDQ) for assessment of health related quality of life among Sri Lankan cirrhotics. Ceylon Med J. 2013;58:156–62.PubMed Ranawaka CK, Miththinda JK, Senanayake SM, et al. Validation of the Sinhala version of the Chronic Liver Disease Questionnaire (CLDQ) for assessment of health related quality of life among Sri Lankan cirrhotics. Ceylon Med J. 2013;58:156–62.PubMed
13.
go back to reference Ray I, Dutta D, Basu P, De BK. Quality of life assessment of patients with chronic liver disease in eastern India using a Bengali translation chronic liver disease questionnaire. Indian J Gastroenterol. 2010;29:187–95.CrossRefPubMed Ray I, Dutta D, Basu P, De BK. Quality of life assessment of patients with chronic liver disease in eastern India using a Bengali translation chronic liver disease questionnaire. Indian J Gastroenterol. 2010;29:187–95.CrossRefPubMed
14.
go back to reference Lam ET, Lam CL, Lai CL, Yuen MF, Fong DY. Psychometrics of the chronic liver disease questionnaire for southern Chinese patients with chronic hepatitis B virus infection. World J Gastroenterol. 2009;15:3288–97.CrossRefPubMedPubMedCentral Lam ET, Lam CL, Lai CL, Yuen MF, Fong DY. Psychometrics of the chronic liver disease questionnaire for southern Chinese patients with chronic hepatitis B virus infection. World J Gastroenterol. 2009;15:3288–97.CrossRefPubMedPubMedCentral
15.
go back to reference Casanovas Taltavull T, Jane Cabre L, Herdman M, Casado Collado A, Pubill BP, Fabregat Prous J. Validation of the Spanish version of the liver disease quality of life instrument among candidates for liver transplant. Transplant Proc. 2007;39:2274–7. Casanovas Taltavull T, Jane Cabre L, Herdman M, Casado Collado A, Pubill BP, Fabregat Prous J. Validation of the Spanish version of the liver disease quality of life instrument among candidates for liver transplant. Transplant Proc. 2007;39:2274–7.
16.
go back to reference Loria A, Escheik C, Gerber NL, Younossi ZM. Quality of life in cirrhosis. Curr Gastroenterol Rep. 2013;15:301.CrossRefPubMed Loria A, Escheik C, Gerber NL, Younossi ZM. Quality of life in cirrhosis. Curr Gastroenterol Rep. 2013;15:301.CrossRefPubMed
17.
go back to reference Yacavone RF, Locke GR 3rd, Provenzale DT, Eisen GM. Quality of life measurement in gastroenterology: what is available? Am J Gastroenterol. 2001;96:285–97.CrossRefPubMed Yacavone RF, Locke GR 3rd, Provenzale DT, Eisen GM. Quality of life measurement in gastroenterology: what is available? Am J Gastroenterol. 2001;96:285–97.CrossRefPubMed
19.
go back to reference Eisen GM, Locke GR 3rd, Provenzale D. Health-related quality of life: a primer for gastroenterologists. Am J Gastroenterol. 1999;94:2017–21.CrossRefPubMed Eisen GM, Locke GR 3rd, Provenzale D. Health-related quality of life: a primer for gastroenterologists. Am J Gastroenterol. 1999;94:2017–21.CrossRefPubMed
20.
go back to reference Tanaka A, Kikuchi K, Miura R, et al. Validation of the Japanese version of the Chronic Liver Disease Questionnaire for the assessment of health-related quality of life in patients with chronic viral hepatitis. Hepatol Res. 2016;46:E45–50.CrossRefPubMed Tanaka A, Kikuchi K, Miura R, et al. Validation of the Japanese version of the Chronic Liver Disease Questionnaire for the assessment of health-related quality of life in patients with chronic viral hepatitis. Hepatol Res. 2016;46:E45–50.CrossRefPubMed
21.
go back to reference Pappa E, Hatzi F, Papadopoulos AA, Niakas D. Psychometrics of the Greek Chronic Liver Disease Questionnaire for measuring HRQL. Gastroenterol Res Pract. 2015;2015:395951.CrossRefPubMedPubMedCentral Pappa E, Hatzi F, Papadopoulos AA, Niakas D. Psychometrics of the Greek Chronic Liver Disease Questionnaire for measuring HRQL. Gastroenterol Res Pract. 2015;2015:395951.CrossRefPubMedPubMedCentral
22.
go back to reference Popovic D, Kovacevic NV, Kisic Tepavcevic DB, et al. Validation of the chronic liver disease questionnaire in Serbian patients. World J Gastroenterol. 2013;19:4950–7.CrossRefPubMedPubMedCentral Popovic D, Kovacevic NV, Kisic Tepavcevic DB, et al. Validation of the chronic liver disease questionnaire in Serbian patients. World J Gastroenterol. 2013;19:4950–7.CrossRefPubMedPubMedCentral
Metadata
Title
Translation and validation of chronic liver disease questionnaire (CLDQ) in Tamil language
Authors
Amit Goel
Karunanithi Arivazhagan
Avani Sasi
Vanathy Shanmugam
Seleena Koshi
Biju Pottakkat
C. P. Lakshmi
Ashish Awasthi
Publication date
01-05-2017
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 3/2017
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-017-0756-2

Other articles of this Issue 3/2017

Indian Journal of Gastroenterology 3/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.